Analysts’ updated eps estimates for Saturday, September 30th:

Emergent Biosolutions (NYSE:EBS) had its outperform rating reiterated by analysts at Wells Fargo & Company. The firm currently has a $43.00 price target on the stock, up from their previous price target of $41.00.

Edwards Lifesciences Corporation (NYSE:EW) had its equal weight rating reiterated by analysts at Barclays PLC. They currently have a $120.00 price target on the stock.

InfraREIT (NYSE:HIFR) had its outperform rating reissued by analysts at Evercore ISI. They currently have a $24.00 price target on the stock.

JAKKS Pacific (NASDAQ:JAKK) had its hold rating reaffirmed by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $3.50 price target on the stock, down from their previous price target of $4.50.

Micron Technology (NASDAQ:MU) had its buy rating reissued by analysts at Goldman Sachs Group, Inc. (The). The firm currently has a $43.00 price target on the stock.

Nike (NYSE:NKE) had its outperform rating reiterated by analysts at Credit Suisse Group. The firm currently has a $63.00 target price on the stock.

Nike (NYSE:NKE) had its buy rating reaffirmed by analysts at Stifel Nicolaus. The firm currently has a $66.00 price target on the stock.

Suburban Propane Partners, L.P. (NYSE:SPH) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $29.00 price target on the stock. According to Zacks, “Suburban Propane Partners, L.P., a publicly traded Delaware limited partnership is engaged, through subsidiaries, in the retail and wholesale marketing of propane and related appliances and services. The Partnership believes it is the third largest retail marketer of propane in the United States, Suburban Propane Partners serves active residential, commercial, industrial and agricultural customers from customer service centers in over 40 states. The Partnership’s operations are concentrated in the east and west coast regions of the United States. “

Sarepta Therapeutics (NASDAQ:SRPT) had its outperform rating reiterated by analysts at Leerink Swann. The firm currently has a $66.00 price target on the stock.

Silver Standard Resources (NASDAQ:SSRM) (TSE:SSO) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “SSR Mining Inc. is a mining company. It focused on the operation, development, exploration and acquisition of precious metal projects. The company primarily explores for gold, silver, and mineral properties. It principally serves electronics, coin fabrication, dentistry, jewelry, other industrial, technology, pharmaceuticals and solar energy markets. SSR Mining Inc, formerly known as Silver Standard Resources Inc, is based in Vancouver, Canada. “

Thomas Cook Group (NASDAQ:TCKGY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Thomas Cook Group Plc provides leisure travel services. The Company owns, operates and manages travel agencies, tour operators and car hire agencies, as well as owning their own aircraft fleet, cruise ships and resort properties. Thomas Cook Group Plc is based in London, United Kingdom. “

Teladoc (NYSE:TDOC) had its outperform rating reaffirmed by analysts at Cowen and Company. Cowen and Company currently has a $39.00 price target on the stock.

vTv Therapeutics (NASDAQ:VTVT) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $6.50 price target on the stock. According to Zacks, “vTv Therapeutics Inc. is a biopharmaceutical company which is engaged in the discovery and development of orally administered small molecule drug candidates to fill unmet medical needs. Its drug candidate for the treatment of Alzheimers disease includes azeliragon TTP488, which is in Phase III clinical trials; type II diabetes drug candidates include Glucokinase Activator TTP399 and GLP-1r Agonist TTP273 which completed Phase I clinical trials; products for the prevention of muscle weakness and treatment of inflammatory disorders include HPP593, HPP737 and HPP971 which is in Phase1 clinical trials. The Company’s drug discovery platform consists of TTP Translational Technology. vTv Therapeutics Inc. is headquartered in High Point, North Carolina. “

Westpac Banking Corporation (NYSE:WBK) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $28.00 target price on the stock. According to Zacks, “Westpac Banking Corp. provides a broad range of banking and financial services. The company offers general banking services to retail, commercial, and institutional customers and provides investment management and insurance. For institutional and international clients, Westpac provides working capital loans, trade financing, foreign currency loans, leveraged leasing, project finance loans, and interest rate and currency products. “

Worthington Industries (NYSE:WOR) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Worthington Industries is one of the leading diversified metal processing companies. The company is one of North America’s premier value-added steel processors and one of the leaders in manufactured metal products such as automotive aftermarket stampings, pressure cylinders, metal framing, metal ceiling grid systems and laser welded blanks. (Company Press Release) “

Xenetic Biosciences (NASDAQ:XBIO) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $2.50 price target on the stock. According to Zacks, “Xenetic Biosciences Inc. is a biopharmaceutical company. It develops biologic drugs, oncology therapeutics and vaccinations. The Company’s proprietary drug technology platforms include PolyXen (R) for the development of next generation biologic drugs and OncoHist (R) for the development of oncology drugs focused on orphan indications. Xenetic Biosciences Inc. based in United States. “

Extraction Oil & Gas (NYSE:XOG) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Extraction Oil & Gas, Inc. is an oil and gas company. It focused on the acquisition, development and production of oil, natural gas and natural gas liquids reserves in the Rocky Mountains, primarily in the Wattenberg Field of the Denver-Julesburg Basin of Colorado. Extraction Oil & Gas, Inc. is based in Denver, United States. “

Receive News & Stock Ratings for Emergent Biosolutions Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emergent Biosolutions Inc and related stocks with our FREE daily email newsletter.